Pfizer Inc's Lipitor and AstraZeneca's Crestor cholesterol drugs, taken at their highest dose, safely reduced artery-clogging plaque in heart patients, according to data from a clinical trial ...
AstraZeneca outspent rivals Pfizer and Merck by 30% on consumer advertising for Crestor, helping the drug become the fastest-growing cholesterol treatment, Bloomberg.com reported.AstraZeneca spent ...
In a head-to-head test of two popular cholesterol-lowering statin drugs — Lipitor and Crestor — both medications worked equally well. Lipitor (atorvastatin) and Crestor (rosuvastatin) both effectively ...
SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...
JUPITER Trial Results, Advantages in Efficacy and Fall Out from Vytorin and Zetia are Likely Drivers of Increased Patient Share for Crestor, According to a New Report from Decision Resources ...
WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE: AZN) today announced results of the LUNAR (Limiting UNdertreatment of Lipids in Acute Coronary Syndrome with Rosuvastatin) study, which showed ...
Although past peak sales, Lipitor, the gold standard therapy and highest selling brand commanded 40% of antidyslipidemic revenues in 2009. This will change dramatically after the loss of its patent ...
There are four abstracts featuring Crestor - two showing it is superior to atorvastatin, another in which it looks better than Merck's Zocor ® (simvastatin) and Bristol-Myers Squibb's Pravachol ® ...
ORLANDO, Fla., Nov 15 (Reuters) - Pfizer Inc's <PFE.N> Lipitor and AstraZeneca's <AZN.L> Crestor cholesterol drugs, taken at their highest dose, safely reduced artery-clogging plaque in heart patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback